Martina Brueckmann Selected Research

Type 2 Diabetes Mellitus (MODY)

4/2024	Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
4/2024	Empagliflozin after Acute Myocardial Infarction.
11/2022	Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
12/2021	Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial.
11/2021	Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
10/2021	Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.
12/2020	Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME.
12/2020	Cost-effectiveness of empagliflozin in the UK in an EMPA-REG OUTCOME subgroup with type 2 diabetes and heart failure.
1/2020	Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.
1/2020	Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina Brueckmann Research Topics

Disease

80	Heart Failure 04/2024 - 07/2005
37	Atrial Fibrillation 01/2023 - 04/2011
33	Stroke (Strokes) 01/2022 - 01/2012
32	Hemorrhage 01/2021 - 02/2012
18	Sepsis (Septicemia) 09/2014 - 03/2003
16	Embolism (Embolus) 01/2019 - 02/2012
14	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2019
13	Myocardial Infarction 04/2024 - 01/2003
11	Venous Thromboembolism 02/2024 - 01/2016
9	Inflammation (Inflammations) 10/2019 - 01/2003
7	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2022
7	Embolic Stroke 01/2022 - 12/2015
7	Aortic Valve Stenosis (Aortic Stenosis) 09/2008 - 10/2003
6	Chronic Renal Insufficiency 04/2024 - 01/2019
6	Thrombosis (Thrombus) 02/2024 - 10/2016
5	Body Weight (Weight, Body) 08/2023 - 12/2020
5	Acute Coronary Syndrome 01/2019 - 01/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2012 - 10/2007
4	Disease Progression 12/2023 - 03/2003
4	Hypotension (Low Blood Pressure) 01/2023 - 01/2021
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 11/2017
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 01/2014
3	Left Ventricular Dysfunction 04/2024 - 08/2008
3	Heart Valve Diseases (Valvular Heart Disease) 08/2016 - 07/2004
3	Edema (Dropsy) 01/2015 - 09/2008
3	Dyspnea (Shortness of Breath) 01/2015 - 09/2008
3	Heart Diseases (Heart Disease) 01/2012 - 01/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 08/2007
2	Kidney Diseases (Kidney Disease) 12/2023 - 01/2023
2	Vascular Diseases (Vascular Disease) 10/2023 - 01/2009
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 10/2022
2	Albuminuria 11/2022 - 01/2021
2	Hypertension (High Blood Pressure) 11/2022 - 01/2007
2	Prediabetic State (Prediabetes) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 10/2019 - 04/2011
2	Neoplasms (Cancer) 05/2017 - 12/2014
2	Thromboembolism 03/2016 - 03/2015
2	Septic Shock (Toxic Shock Syndrome) 09/2014 - 03/2003
2	Unstable Angina 02/2012 - 01/2007
2	Infections 01/2009 - 05/2004
2	Ventricular Tachycardia 10/2007 - 01/2004
2	Supraventricular Tachycardia 01/2007 - 01/2004
2	Tachycardia (Tachyarrhythmias) 06/2004 - 01/2004
1	Congenital Heart Defects (Congenital Heart Defect) 02/2024
1	Weight Loss (Weight Reduction) 01/2023

Drug/Important Bio-Agent (IBA)

67	empagliflozinIBA 04/2024 - 11/2017
49	Dabigatran FDA Link 02/2024 - 01/2012
27	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2012
21	AnticoagulantsIBA 01/2021 - 01/2012
15	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2017
15	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2004
14	SodiumIBA 12/2022 - 11/2017
13	Sodium-Glucose Transport ProteinsIBA 04/2024 - 10/2020
13	pro-brain natriuretic peptide (1-76)IBA 08/2023 - 01/2004
12	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 11/2017
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 07/2005
9	SymportersIBA 12/2022 - 11/2017
9	Thrombin FDA Link 09/2022 - 12/2015
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 12/2015
8	Natriuretic PeptidesIBA 10/2022 - 07/2005
7	Protein CIBA 09/2012 - 01/2003
7	Matrix Metalloproteinases (MMPs)IBA 01/2009 - 01/2003
6	Vitamin K FDA Link 01/2021 - 01/2014
5	CreatinineIBA 12/2023 - 06/2015
5	DiureticsIBA 08/2023 - 10/2019
5	drotrecogin alfa activated (Xigris)FDA Link 12/2008 - 03/2003
4	AlbuminsIBA 12/2023 - 01/2021
4	Troponin T (Troponin T1)IBA 11/2022 - 01/2021
4	Clopidogrel (Plavix)FDA Link 01/2019 - 06/2008
4	RivaroxabanIBA 01/2019 - 01/2012
4	Interleukin-6 (Interleukin 6)IBA 09/2014 - 01/2006
4	CytokinesIBA 09/2012 - 01/2004
4	Atrial Natriuretic Factor (ANF)IBA 08/2008 - 01/2004
3	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2021
3	Uric Acid (Urate)IBA 01/2023 - 01/2022
3	Troponin IIBA 06/2015 - 01/2005
3	apixabanIBA 12/2014 - 01/2012
3	EnzymesIBA 08/2012 - 03/2005
3	AdrenomedullinIBA 01/2010 - 01/2008
3	CalciumIBA 08/2007 - 07/2004
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2007 - 01/2005
2	Insulin (Novolin)FDA Link 04/2024 - 12/2021
2	Hormones (Hormone)IBA 01/2023 - 11/2022
2	Neprilysin (Neutral Endopeptidase)IBA 11/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 04/2018
2	TroponinIBA 01/2021 - 11/2017
2	dapagliflozinIBA 01/2020 - 10/2019
2	TicagrelorIBA 01/2019 - 01/2019
2	AntibodiesIBA 01/2018 - 07/2004
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 11/2005
2	Indicators and Reagents (Reagents)IBA 09/2008 - 08/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2005 - 01/2003

Therapy/Procedure

37	Therapeutics 12/2023 - 03/2003
6	Critical Care (Surgical Intensive Care) 01/2021 - 03/2003
4	Secondary Prevention 02/2024 - 07/2018
4	Percutaneous Coronary Intervention 01/2019 - 01/2007
3	Catheter Ablation 11/2013 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2018 - 04/2006